This snapshot, taken on
05/11/2010
, shows web content acquired for preservation by The National Archives. External links, forms and search may not work in archived websites and contact details are likely to be out of date.
 
 
The UK Government Web Archive does not use cookies but some may be left in your browser from archived websites.

Site navigation

Navigation

Multiple myeloma (first line) - bortezomib and thalidomide

Bortezomib and thalidomide for the first-line treatment of multiple myeloma

Status: In progress
Expected date of issue: 2010-10-27 00:00:00.0
Referral date: 2009-03-01 00:00:00.0
Wave: 18
Process: MTA
Topic area:
  • Cancer
 

NICE project team

Executive Lead: Andrew Dillon
Technical Lead: Carina Righetti
Communications manager: Alice Law
Project manager: Lori Farrar
Assessment group: Southampton Health Technology Assessment Centre (SHTAC) University of Southampton
Top


 

Provisional schedule

Closing date for invited submissions / evidence submission: 8 October 2009
1st appraisal committee meeting: 2010-04-13 00:00:00.0
2nd appraisal committee meeting 2010-07-08 00:00:00.0
Top


 

Consultees and commentators

Consultees Commentators (no right to submit or appeal)

Manufacturers/sponsors

  • Janssen-Cilag (bortezomib)
  • Celgene (thalidomide)

 

Patient / carer Groups

  • Leukaemia CARE
  • Macmillan Cancer Support
  • Myeloma UK
  • Rarer Cancers Foundation

Professional groups

  • British Society for Haematology
  • Royal College of Nursing
  • Royal College of Pathologists
  • Royal College of Physicians, Medical Oncology Joint Special Committee
  • UK Myeloma Forum

 

Others

  • Department of Health
  • Hammersmith and Fulham PCT
  • Welsh Assembly Government

General

  • Commissioning Support Appraisals Service
  • Department of Health, Social Services and Public Safety - Northern Ireland (DHSSPSNI)
  • NHS Quality Improvement Scotland

 

Comparator manufacturers

  • GlaxoSmithKline (melphalan)

 

Relevant research groups

  • Leukaemia and Lymphoma Research
  • Clinical Trials Research Unit (CTRU), University of Leeds

 

Assessment Group

  • National Institute for Health Research Health Technology Assessment Programme
  • Southampton Health Technology Assessment Centre, University of Southampton

 

Associated Guideline Groups

  • National Collaborating Centre for Cancer

 

Associated Public Health Groups

  • None

Top


 

Key documents

This page was last updated: 24 September 2010